Warner Robert Keith 4
4 · RxSight, Inc. · Filed Jan 9, 2024
Insider Transaction Report
Form 4
RxSight, Inc.RXST
Warner Robert Keith
Director
Transactions
- Sale
Common Stock
2024-01-08$42.37/sh−16,530$700,389→ 7,220 total(indirect: See footnote) - Sale
Common Stock
2024-01-08$43.42/sh−7,220$313,505→ 0 total(indirect: See footnote)
Holdings
- 27,733
Common Stock
Footnotes (4)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on August 24, 2023 by the Reporting Person.
- [F2]Represents the weighted average share price of an aggregate total of 16,530 shares sold in the price range of $42.00 to $42.995 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Shares held by the Cabo Living Trust, for which the Reporting Person serves as trustee.
- [F4]Represents the weighted average share price of an aggregate total of 7,220 shares sold in the price range of $43.085 to $43.98 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.